Medical Therapies and Building Your Care Team

A new diagnosis means adapting to a new kind of medical care. Managing Familial Chylomicronemia Syndrome (FCS) requires a shift in how you think about medicine. Because your body lacks the functional “machinery” to clear fat efficiently, many of the standard drugs that lower triglycerides in the general population often behave differently for you ^[1][2].

The Role of Standard Lipid Drugs

If you have been prescribed fibrates, statins, or high-dose omega-3s (fish oil) without seeing major triglyceride reductions, it is a known hallmark of your condition. These conventional medications mostly rely heavily on the Lipoprotein Lipase (LPL) pathway ^[3]. Because FCS is defined by a complete or near-complete impairment in that very pathway, these drugs often have limited efficacy in drastically lowering chylomicron-driven triglycerides ^[1].

For many patients, continuing these medications while triglycerides remain dangerously high (often over 1,000 or 2,000 mg/dL) provides a false sense of security without actually reducing the risk of pancreatitis ^[4][2]. However, never stop or change a prescribed medication without speaking with your prescriber. Statins, for example, primarily address LDL cholesterol and cardiovascular risk, and you may have secondary lipid issues that require these treatments.

Targeted Therapies: A New Approach

Scientists have developed newer “targeted” therapies that alter chylomicron and remnant metabolism, often involving LPL-independent pathways. These drugs focus on a protein called ApoC-III, which normally acts as a “brake” on fat clearance. By inhibiting this protein, these medicines help the body clear triglycerides more effectively as an adjunct to diet ^[5][6].

• Volanesorsen: This was the first targeted therapy for FCS. In clinical trials, it reduced triglycerides by an average of 77% ^[7]. However, it can cause thrombocytopenia (a dangerous drop in blood platelets) and frequent injection-site reactions, so it requires very strict and frequent platelet monitoring ^[7][8]. It is approved for use in the European Union and several other regions ^[9].
• Olezarsen: A monthly injection recently approved by the US FDA (late 2024) as an adjunct to diet to reduce triglycerides in adults with FCS ^[10]. In the BALANCE trial, it significantly reduced fasting triglycerides and was associated with a lower rate of acute pancreatitis events ^[11]. Monitoring guidelines are detailed in the product label and typically focus on liver enzymes and standard blood counts, without the intense platelet protocol of volanesorsen ^[12].
• Plozasiran: This is a quarterly (four times per year) injection that has also been recently approved by the US FDA for treating FCS ^[13][14]. While generally well-tolerated in trials, patients must be monitored for side effects as per the regulatory label, which can include abdominal pain or changes in blood sugar (hyperglycemia) ^[13].

Another class of drugs, ANGPTL3 inhibitors (like Evinacumab), is used for other cholesterol conditions but has shown very limited success in FCS because these drugs still rely on having some working LPL enzymes ^[15][6]. Note: Any investigational or regionally unavailable drug should only be used under strict specialist supervision.

Building Your Multidisciplinary Team

Because FCS affects so many parts of your life, you need a “team captain” and several specialists who understand this ultra-rare condition ^[16]:

1. The Team Captain (Lipidologist or Endocrinologist): You need a specialist who focuses on lipid metabolism. They will coordinate your medications and monitor your lab work for both triglycerides and drug safety ^[17].
2. The Metabolic Dietitian: This is perhaps your most important daily partner. They must be an expert in very-low-fat medical diets and help you manage your intake of essential fats and fat-soluble vitamins (A, D, E, K) ^[16][18].
3. The Pancreas Specialist (Gastroenterologist): If you have a history of pancreatitis, a GI specialist can help monitor for long-term complications like exocrine pancreatic insufficiency (where you need enzyme pills to digest food) or chronic scarring ^[16].
4. Mental Health Support: Living with a severe, rare genetic condition and a highly restrictive diet is a significant burden. Counselors can help with the emotional and social challenges of FCS ^[18].

When looking for a team, ask if they have ever treated an FCS patient before. Because it is so rare, you may need to seek care at a major university hospital or a specialized lipid center ^[16].